[1]
BelliC., “Clinical and Translational Results of a Phase II Randomized Trial of Maintenance Sunitinib or Observation in Metastatic Pancreatic Adenocarcinoma”, JOP, vol. 13, no. 5S, p. 551, Sep. 2012.